Haemostasis Flashcards
What are the general principles of haemostasis?
To prevent bleeding and prevent unnecessary coagulation, allowing blood to flow§
Describe the response to vascular injury
- platelet-collagen adhesion
- platelet aggregation
- fibrinogen attaches and
How are platelets formed?
- Megakaryocytes produce platelets in the bone marrow
- Platelets ‘bud’ from cytoplasm
- Normal life span is 7-10 days (anti platelet drugs must be stopped 7-10 days before surgery)
How do platelets adhere to vessels?
Damage to vessel wall
•Exposure of underlying tissues
•Platelets adhere to collagen via vWF/receptor
Once initial platelets have attached to vessel walls, how do platelets aggregate?
- Secrete ADP, thromboxane and other substances to become activated and activate other platelets
- Involved in activation of the clotting cascade
- Provide some coagulation factors by secretion from internal stores
- Finally, they aggregate by cross linking of platelets to form a platelet plug
Outline some targets for anti-platelet drugs
• Plt receptors –glycoprotein complexes e.g. GP1b-V-IX, GPIIb-IIIa • Von willebrands factor • Fibrinogen • Collagen • ADP • Thromboxane/arachidonic acid • Thrombin
What is the blood clotting cascade?
Amplification system activation of precursor proteins to generate thrombin (IIa)
- Thrombin converts soluble fibrinogen into insoluble fibrin
- which enmeshes initial platelet plug to make stable clot
It is controlled by:
–Natural anticoagulants to inhibit activation
–Clot destroying proteins which are activated by the clotting
How is the blood clotting cascade initiated?
-
What is the role of Von Willebrand’s factor in blood clotting cascade?
Involved in platelet adhesion to the vessel
wall, platelet aggregation, and also carries FVIII
What role does the vessel wall play in the blood clotting cascade?
- Vasoconstriction
• Production of Von Willebrandsfactor (vWF) –Essential for platelet adhesion –Carrier and ‘protector’ of Factor 8 (clotting protein)
• Exposure of collagen and Tissue factor
which initiates activation of clotting factors (proteins)